DuPont named AnnaMaria DeSalva vice president of corporate communications. In the newly established role, DeSalva, will be responsible for leading, developing and executing the company's strategic communications and brand management around the world.
DeSalva has more than 20 years of experience in science-related communications and branding, including a variety of progressive leadership positions with Pfizer, Hill & Knowlton, GCI Group and Bristol-Myers Squibb. Most recently, DeSalva has served as vice president, Corporate Affairs - Biopharma Innovation & Outcomes, at Pfizer where she has been responsible for leading science, medicine, portfolio and strategy corporate affairs. DeSalva is a board director for the National Campaign to End Obesity as well as for INMED Partnerships for Children and she has served as a risk communications adviser to the U.S. Food and Drug Administration.
